KeyCorp reissued their hold rating on shares of Teleflex Incorporated (NYSE:TFX) in a research report report published on Wednesday.

Other equities analysts have also issued research reports about the company. Barclays PLC reaffirmed a buy rating on shares of Teleflex in a research report on Monday, June 26th. Zacks Investment Research raised Teleflex from a hold rating to a buy rating and set a $228.00 price target for the company in a research report on Friday, June 23rd. Needham & Company LLC reaffirmed a buy rating on shares of Teleflex in a research report on Friday, August 4th. Jefferies Group LLC reaffirmed a buy rating and issued a $230.00 price target on shares of Teleflex in a research report on Thursday, August 3rd. Finally, Deutsche Bank AG reaffirmed a buy rating and issued a $238.00 price target (up previously from $220.00) on shares of Teleflex in a research report on Wednesday, August 9th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. Teleflex has a consensus rating of Buy and an average price target of $246.00.

Shares of Teleflex (NYSE:TFX) traded up 2.47% during mid-day trading on Wednesday, hitting $232.75. 539,406 shares of the stock traded hands. The company’s 50-day moving average price is $211.66 and its 200 day moving average price is $202.56. Teleflex has a 1-year low of $136.53 and a 1-year high of $235.18. The company has a market capitalization of $10.48 billion, a PE ratio of 44.51 and a beta of 1.05.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.91 by $0.13. The firm had revenue of $528.60 million during the quarter, compared to analyst estimates of $518.98 million. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. Teleflex’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.89 EPS. Equities research analysts forecast that Teleflex will post $8.28 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This news story was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of United States and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/09/teleflexs-tfx-hold-rating-reiterated-at-keycorp.html.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Tuesday, August 15th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s dividend payout ratio (DPR) is 26.00%.

In other Teleflex news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $208.41, for a total value of $41,682.00. Following the completion of the transaction, the director now owns 8,080 shares of the company’s stock, valued at approximately $1,683,952.80. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Gretchen R. Haggerty bought 1,000 shares of the firm’s stock in a transaction on Wednesday, June 21st. The stock was acquired at an average cost of $203.82 per share, with a total value of $203,820.00. Following the transaction, the director now owns 1,760 shares in the company, valued at approximately $358,723.20. The disclosure for this purchase can be found here. In the last three months, insiders sold 600 shares of company stock valued at $125,652. 2.39% of the stock is owned by insiders.

Large investors have recently modified their holdings of the business. Toronto Dominion Bank raised its position in Teleflex by 14.5% in the 2nd quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after buying an additional 70 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in Teleflex in the 1st quarter worth about $155,000. Advisory Services Network LLC raised its position in Teleflex by 933.8% in the 2nd quarter. Advisory Services Network LLC now owns 827 shares of the medical technology company’s stock worth $172,000 after buying an additional 747 shares during the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. raised its position in Teleflex by 200.0% in the 1st quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock worth $174,000 after buying an additional 600 shares during the last quarter. Finally, Cornerstone Capital Management Holdings LLC. purchased a new position in Teleflex in the 2nd quarter worth about $175,000. 90.50% of the stock is owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Analyst Recommendations for Teleflex (NYSE:TFX)

Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.